申请人:——
公开号:US20020040048A1
公开(公告)日:2002-04-04
The present invention relates to a pyrrolidine compound and pharmaceutically acceptable esters and/or salts thereof. The compounds are useful as inhibitors of metalloproteases, e.g. zinc proteases, particularly zinc hydrolases, and which are effective in treating disease states are associated with vasoconstriction of increasing occurrences.
本发明涉及吡咯烷化合物及其药用可接受的酯和/或盐。这些化合物可用作金属蛋白酶抑制剂,例如锌蛋白酶,特别是锌水解酶,对治疗与血管收缩增加发生相关的疾病状态有效。